As a result, ACPs of this type have a promising clinical future
Experimental research suggests potential effects in tissue repair, inflammation control, and regenerative signaling, but clinical evidence remains limited
The queries from databases have resulted in 565 publications
If GI side effects are manageable, add cagrilintide at 0.25 mg weekly starting in week 5, while simultaneously increasing retatrutide to 2 mg as per its standard titration
This article describes the efficacy of using orforglipron as a maintenance therapy after treatment with semaglutide or tirzepatide at maximum tolerated dose
[DOI] [PubMed] [Google Scholar] [72].Page AE, Slovis NM, Horohov DW